Faure E, Royer-Carenzi M:Is the European spatial distribution of the HIV-1-resistant CCR5-Delta32 allele formed by a breakdown of the pathocenosis due to the historical Roman expansion? In: Infect. Genet. Evol. 8. Jahrgang, Nr.6, Dezember 2008, S.864–74, doi:10.1016/j.meegid.2008.08.007, PMID 18790087 (englisch).
W. G. Glass, D. H. McDermott u.a.: CCR5 deficiency increases risk of symptomatic West Nile virus infection. In: The Journal of experimental medicine Band 203, Nummer 1, Januar 2006, S.35–40. doi:10.1084/jem.20051970. PMID 16418398. PMC211808(freier Volltext).
J. K. Lim, C. Y. Louie u.a.: Genetic deficiency of chemokine receptor CCR5 is a strong risk factor for symptomatic West Nile virus infection: a meta-analysis of 4 cohorts in the US epidemic. In: The Journal of Infectious Diseases Band 197, Nummer 2, Januar 2008, S.262–265. doi:10.1086/524691. PMID 18179388.
Murphy PM, Baggiolini M, Charo IF, et al.:International union of pharmacology. XXII. Nomenclature for chemokine receptors. In: Pharmacological Reviews. 52. Jahrgang, Nr.1, März 2000, S.145–76, PMID 10699158 (englisch).
Galvani AP, Slatkin M:Evaluating plague and smallpox as historical selective pressures for the CCR5-Delta 32 HIV-resistance allele. In: Proc. Natl. Acad. Sci. USA. 100. Jahrgang, Nr.25, Dezember 2003, S.15276–9, doi:10.1073/pnas.2435085100, PMID 14645720, PMC299980(freier Volltext) – (englisch).
Biloglav Z, Zgaga L, Smoljanović M, et al.:Historic, demographic, and genetic evidence for increased population frequencies of CCR5Delta32 mutation in Croatian Island isolates after lethal 15th century epidemics. In: Croat. Med. J. 50. Jahrgang, Nr.1, Februar 2009, S.34–42, PMID 19260142, PMC2657566(freier Volltext) – (englisch).
Faure E, Royer-Carenzi M:Is the European spatial distribution of the HIV-1-resistant CCR5-Delta32 allele formed by a breakdown of the pathocenosis due to the historical Roman expansion? In: Infect. Genet. Evol. 8. Jahrgang, Nr.6, Dezember 2008, S.864–74, doi:10.1016/j.meegid.2008.08.007, PMID 18790087 (englisch).
W. G. Glass, D. H. McDermott u.a.: CCR5 deficiency increases risk of symptomatic West Nile virus infection. In: The Journal of experimental medicine Band 203, Nummer 1, Januar 2006, S.35–40. doi:10.1084/jem.20051970. PMID 16418398. PMC211808(freier Volltext).
J. K. Lim, C. Y. Louie u.a.: Genetic deficiency of chemokine receptor CCR5 is a strong risk factor for symptomatic West Nile virus infection: a meta-analysis of 4 cohorts in the US epidemic. In: The Journal of Infectious Diseases Band 197, Nummer 2, Januar 2008, S.262–265. doi:10.1086/524691. PMID 18179388.